Study to Estimate Efficacy of Combining Dostarlimab and Niraparib in Relapsed EOC After Treatment With PARPi

Clinical trial NCT05126342 · WITHDRAWN

Trial details

NCT number: NCT05126342
Sponsor: AGO Research GmbH
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Ovarian Cancer Recurrent Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2023-11-01
Primary completion: 2024-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.